Home » Trials » SLCTR/2008/016


Efficacy of antioxidant therapy in acute paraquat poisoning

-

SLCTR Registration Number

SLCTR/2008/016


Date of Registration

22 Aug 2008

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

Efficacy of antioxidant therapy in acute paraquat poisoning


Public Title of Trial

Improvement following acute paraquat poisoning due to antioxidant therapy


Disease or Health Condition(s) Studied

Acute paraquat intoxication


Scientific Acronym

None


Public Acronym

None


Brief title

Antioxidant trial


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

Would antioxidants (intravenous vitamin C or intravenous vitamin C to paraquat?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Treatment


Study Phase

Not Available


Intervention(s) planned

Apart from the standard management (Fernando, 1998), patients will be given intra venous vitamin C as follow, 100 mg, 500 mg, 1000 mg, 3000 mg/day and 3000 mg/ 8 h for 5 consecutive days. S. Y. Hong et al (2002) stated that white blood cell count (WBC), serum Aspartate amino transferase (GOT) and arterial blood PaO2 were significantly decrease (from 9* 103 ± 564 mm3 to 8.5* 103 ± 347 mm3; p<0.05, from 27.0 ± 3.8 IU to 22.0 ± 2.7 IU; p<0.01 and from 99.5 ± 3.4 mmHg to 87.3 ± 7.1 mmHg ; p<0.001 respectively) during the observation period after administration of Intravenous vitamin C. They also noted that when the amount of vitamin C increased to 3000 mg, patients complained pain around the injection site(Hong et al., 2002). Therefore after each dose pulse rate, blood pressure, respiratory rate, body temperature will be monitored every 6 hours and white blood cell count (WBC), liver and renal function tests, urine analysis and oxygen saturation will be conducted every day. In the treatment of paracetamol poisoning N-acetylcysteine (NAC) is given in an initial dose of 150 mg/kg in 200 ml 5% dextrose over 15 minutes followed by 50 mg/kg in 500 ml 5% dextrose over four hours and 100 mg/kg in one litre 5% dextrose over the next 16 hours (total dose 300 mg/kg in 20 hours) (Fernando, 1998; L F Prescott, 1979) But rashes and anaphylaxis are known adverse effects of N-acetylcysteine with the dose given in paracetamol poisoning. Therefore I would like to propose a regimen for NAC which can be used in paraquat intoxication. Proposed NAC regimen for paraquat intoxication will be as follow; Initially 20 mg/kg in 200mL of 5% dextrose over 15 minutes Followed by 50 mg/kg in 500mL over 12 hours (? 4 mg/h/kg) twice per day for 3 days The total dose will be 320 mg/kg in 72 hours


Inclusion criteria

Consecutive patients who get admitted to General Hospital, Matara following history of acute exposure to paraquat and symptoms suggestive of acute exposure to paraquat will be selected for the study


Exclusion criteria

• Unconscious patients • Pregnant mothers



Primary outcome(s)

1.

Improvement of total antioxidant status in plasma after administration of Intra Venous vitamin C+placebo or vitamin C + NAC

[

First five consecutive days of acute exposure to paraquat

]

Secondary outcome(s)

1.

Improvement of survival

[

Two months after acute exposure to paraquat

]

Target number/sample size

40


Countries of recruitment

Sri Lanka


Anticipated start date

2008-08-01


Anticipated end date

2009-08-31


Date of first enrollment


Date of study completion


Recruitment status

Complete: follow up complete


Funding source

South Asian Clinical Toxicology Research Collaboration


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2008-08-19


Approval number

Not Available


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Ruhuna
Institutional Address:PO Box 70, Labuduwa Rd, Galle, Sri Lanka
Telephone:+94-91-2234801/803 (Extension: 161)
Email: ethics@med.ruh.ac.lk

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr Sudheera Jayasinghe
Probationary Lecturer
Faculty of Medicine, University of Ruhuna
+94 91 2246877

+94 91 2222314
sudheerasj@yahoo.com

Contact Person for Public Queries

Dr Sudheera Jayasinghe
Probationary Lecturer
Faculty of Medicine, University of Ruhuna
+94 91 2246877

+94 91 2222314
sudheerasj@yahoo.com


Primary study sponsor/organization

South Asian Clinical Toxicology Research Collaboration

Faculty of Medicine, University of Peradeniya, Sri Lanka
+94 81 2384556

adawson@sactrc.com

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description

Not Available


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results